UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 143

Sortiert nach

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

Hepatology (Baltimore, Md.), 2023-05, Vol.77 (5), p.1797-1835

2023

Link zum Volltext

Verfügbarkeit prüfen

From NAFLD to MAFLD: Implications of a Premature Change in Terminology

Hepatology (Baltimore, Md.), 2021-03, Vol.73 (3), p.1194-1198

2021

Link zum Volltext

Verfügbarkeit prüfen

Nonalcoholic Fatty Liver Disease, Diabetes, Obesity, and Hepatocellular Carcinoma

Clinics in liver disease, 2015-05, Vol.19 (2), p.361-379

2015

Link zum Volltext

Verfügbarkeit prüfen

Nonalcoholic fatty liver disease: a systematic review

JAMA : the journal of the American Medical Association, 2015-06, Vol.313 (22), p.2263

Rinella, Mary E

2015

Link zum Volltext

Verfügbarkeit prüfen

From NAFLD to MASLD: updated naming and diagnosis criteria for fatty liver disease

Journal of lipid research, 2024-01, Vol.65 (1), p.100485-100485, Article 100485

2024

Link zum Volltext

Verfügbarkeit prüfen

Nonalcoholic Fatty Liver Disease: Identification and Management of High-Risk Patients

The American journal of gastroenterology, 2019-04, Vol.114 (4), p.579-590

2019

Link zum Volltext

Verfügbarkeit prüfen

The Role of Diet and Nutrient Composition in Nonalcoholic Fatty Liver Disease

Journal of the Academy of Nutrition and Dietetics, 2012-03, Vol.112 (3), p.401-409

2012

Link zum Volltext

Verfügbarkeit prüfen

Report on the AASLD/EASL Joint Workshop on Clinical Trial Endpoints in NAFLD

Hepatology (Baltimore, Md.), 2019-10, Vol.70 (4), p.1424-1436

2019

Link zum Volltext

Verfügbarkeit prüfen

Preparing for the NASH Epidemic: A Call to Action

Gastroenterology, 2021-09, Vol.161 (3), p.1030-1042.e8

2021

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet

Journal of lipid research, 2008-05, Vol.49 (5), p.1068-1076

2008

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal Association of Non-Alcoholic Fatty Liver Disease With Changes in Myocardial Structure and Function: The CARDIA Study

Journal of the American Heart Association, 2020-02, Vol.9 (4), p.e014279-e014279

2020

Link zum Volltext

Verfügbarkeit prüfen

Pegozafermin for NASH — A Sprint to Start a Marathon

The New England journal of medicine, 2023-09, Vol.389 (11), p.1044-1046

Rinella, Mary E.

2023

Link zum Volltext

Verfügbarkeit prüfen

Will the increased prevalence of nonalcoholic steatohepatitis (NASH) in the age of better hepatitis C virus therapy make NASH the deadlier disease?

Hepatology (Baltimore, Md.), 2011-10, Vol.54 (4), p.1118-1120

Rinella, Mary E.

2011

Link zum Volltext

Verfügbarkeit prüfen

Management of NAFLD: a stage-based approach

Nature reviews. Gastroenterology & hepatology, 2016-04, Vol.13 (4), p.196

2016

Link zum Volltext

Verfügbarkeit prüfen

Steatotic liver disease: a new name to reflect the combined role of alcohol and metabolic dysfunction

Nature medicine, 2024-04, Vol.30 (4), p.933-936

2024

Link zum Volltext

Verfügbarkeit prüfen

STELLAR 3 and STELLAR 4: Lessons from the fall of Icarus

Journal of hepatology, 2020-07, Vol.73 (1), p.9-11

2020

Link zum Volltext

Verfügbarkeit prüfen

Pioneering the path to NASH biomarker approval

Nature medicine, 2023-10, Vol.29 (10), p.2416-2417

2023

Link zum Volltext

Verfügbarkeit prüfen

Practice patterns in NAFLD and NASH: real life differs from published guidelines

Therapeutic advances in gastroenterology, 2016-01, Vol.9 (1), p.4-12

2016

Link zum Volltext

Verfügbarkeit prüfen

Pentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trial

Annals of hepatology, 2011-07, Vol.10 (3), p.277-286

2011

Link zum Volltext

Verfügbarkeit prüfen

Examining the Nomenclature Change From NAFLD and NASH to MASLD and MASH

Gastroenterology & hepatology, 2023-11, Vol.19 (11), p.697-699

Rinella, Mary E

2023

Link zum Volltext

Verfügbarkeit prüfen

Systematic review with meta‐analysis: risk of hepatocellular carcinoma in non‐alcoholic steatohepatitis without cirrhosis compared to other liver diseases

Alimentary pharmacology & therapeutics, 2018-10, Vol.48 (7), p.696-703

2018

Link zum Volltext

Verfügbarkeit prüfen

American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD)

Endocrine practice, 2022-05, Vol.28 (5), p.528-562

2022

Link zum Volltext

Verfügbarkeit prüfen

A Myriad of Pathways to NASH

Clinics in liver disease, 2012-08, Vol.16 (3), p.525-548

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 143

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(139)
Mit Volltextzugriff
(109)

Publikationsform

Artikel
(142)
Buchkapitel
(1)

Sprache

Englisch
(143)
Japanisch
(23)

Erscheinungsjahr

n.n

Thema

Science & Technology
(98)
Life Sciences & Biomedicine
(97)
Humans
(83)
Gastroenterology & Hepatology
(73)
Fatty Liver
(30)
Female
(29)
Liver Diseases
(29)
Hepatology
(26)
Male
(25)
Non-Alcoholic Fatty Liver Disease - Diagnosis
(25)
Liver
(23)
Risk Factors
(23)
Fibrosis
(19)
Adult
(18)
Middle Aged
(18)
Cirrhosis
(16)
Non-Alcoholic Fatty Liver Disease
(16)
Nafld
(15)
Nash
(15)
Non-Alcoholic Fatty Liver Disease - Epidemiology
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

From NAFLD to MAFLD: Implications of a Premature Change in Terminology

Nonalcoholic Fatty Liver Disease, Diabetes, Obesity, and Hepatocellular Carcinoma

Nonalcoholic fatty liver disease: a systematic review

From NAFLD to MASLD: updated naming and diagnosis criteria for fatty liver disease

Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis

Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

Nonalcoholic Fatty Liver Disease: Identification and Management of High-Risk Patients

The Role of Diet and Nutrient Composition in Nonalcoholic Fatty Liver Disease

Report on the AASLD/EASL Joint Workshop on Clinical Trial Endpoints in NAFLD

Preparing for the NASH Epidemic: A Call to Action

Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet

Longitudinal Association of Non-Alcoholic Fatty Liver Disease With Changes in Myocardial Structure and Function: The CARDIA Study

Pegozafermin for NASH — A Sprint to Start a Marathon

Will the increased prevalence of nonalcoholic steatohepatitis (NASH) in the age of better hepatitis C virus therapy make NASH the deadlier disease?

Management of NAFLD: a stage-based approach

Steatotic liver disease: a new name to reflect the combined role of alcohol and metabolic dysfunction

STELLAR 3 and STELLAR 4: Lessons from the fall of Icarus

Pioneering the path to NASH biomarker approval

Practice patterns in NAFLD and NASH: real life differs from published guidelines

Pentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trial

Examining the Nomenclature Change From NAFLD and NASH to MASLD and MASH

Systematic review with meta‐analysis: risk of hepatocellular carcinoma in non‐alcoholic steatohepatitis without cirrhosis compared to other liver diseases

American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD)

A Myriad of Pathways to NASH

Suchergebnisse filtern